2005
DOI: 10.1124/dmd.105.005306
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of Molybdenum Hydroxylases in Reductive Metabolism of Nitro Polycyclic Aromatic Hydrocarbons in Mammalian Skin

Abstract: ABSTRACT:Molybdenum hydroxylases, aldehyde oxidase and xanthine oxidoreductase, were shown to be involved in the nitroreduction of 2-nitrofluorene (NF), 1-nitropyrene, and 4-nitrobiphenyl, environmental pollutants, in the skin of various mammalian species. NF was reduced to 2-aminofluorene by hamster skin cytosol in the presence of 2-hydroxypyrimidine, 4-hydroxypyrimidine, N 1 -methylnicotinamide, or benzaldehyde, but not hypoxanthine or xanthine. Inhibitors of aldehyde oxidase markedly inhibited these nitrore… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(15 citation statements)
references
References 36 publications
0
15
0
Order By: Relevance
“…Nitroreductases have been suggested to play a role in the metabolic activation of 1-NP in cultured human liver cells (Silvers et al, 1997;Sun et al, 2004). Both xanthine oxidase and NAD(P)H:quinone oxidoreductase 1 have been associated with nitroreduction of 1-NP and are expressed in the vascular wall (Saito et al, 1984;Siegel and Ross, 2000;Ueda et al, 2005;Zhu et al, 2007). We employed dicoumarol, an inhibitor of xanthine oxidase and NAD(P)H:quinone oxidoreductase 1, to reduce the nitroreductive metabolism in HUVEC (Gustafson and Pritsos, 1992).…”
Section: Discussionmentioning
confidence: 97%
“…Nitroreductases have been suggested to play a role in the metabolic activation of 1-NP in cultured human liver cells (Silvers et al, 1997;Sun et al, 2004). Both xanthine oxidase and NAD(P)H:quinone oxidoreductase 1 have been associated with nitroreduction of 1-NP and are expressed in the vascular wall (Saito et al, 1984;Siegel and Ross, 2000;Ueda et al, 2005;Zhu et al, 2007). We employed dicoumarol, an inhibitor of xanthine oxidase and NAD(P)H:quinone oxidoreductase 1, to reduce the nitroreductive metabolism in HUVEC (Gustafson and Pritsos, 1992).…”
Section: Discussionmentioning
confidence: 97%
“…Of the factors, skin may be of particular significance because it takes part in N 1 -methylnicotinamide detoxification and excretion, respectively, through skin AOX [26,27] and sweat glands [28] . We thus explored the role of skin by analyzing human sweat excretion of nicotinamide and N 1 -methylnicotinamide after nicotinamide loading, or by assessing changes in plasma N 1 -methylnicotinamide clearance of rats with severe skin damage.…”
Section: Skin Involvement In N 1 -Methylnicotinamide-mediated Insulinmentioning
confidence: 99%
“…AO belongs to a family of enzymes referred to as molybdenum cofactor-containing enzymes that also include xanthine oxidase . AO is predominantly expressed in the liver, lung, and kidney, and is present in the intestine (Moriwaki et al, 2001;Ueda et al, 2005;Sahi et al, 2008). It is involved in the phase I metabolism of xenobiotics, including anti-infectives, anticancer compounds, antiepileptics, and antipsychotics (Rashidi et al, 1997;Al-Salmy, 2001;Beedham et al, 2003;Obach, 2004;Obach et al, dx.doi.org/10.1124/dmd.116.071100. s This article has supplemental material available at dmd.aspetjournals.org.…”
Section: Introductionmentioning
confidence: 99%